Frec Markets’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.74M Buy
27,814
+8,287
+42% +$524K 0.11% 181
2026
Q2
$1.13M Sell
19,527
-5,621
-22% -$323K 0.1% 204
2026
Q1
$1.53M Buy
25,148
+15,146
+151% +$883K 0.26% 62
2025
Q4
$540K Buy
+10,002
New +$481K 0.16% 119

Other funds holding BMY

Frec Markets's BMY Position: Q3 2026 in Review

Frec Markets increased its Bristol-Myers Squibb (BMY) stake by 42% in Q3 2026, buying an estimated $524K and bringing the position to 27,814 shares worth $1.74M. The position accounts for 0.11% of the portfolio, ranked #181.

Frec Markets first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Frec Markets held 27,814 shares of Bristol-Myers Squibb worth $1.74M as of Q3 2026.
  • Frec Markets bought 8,287 Bristol-Myers Squibb shares in Q3 2026, an estimated $524K.
  • Bristol-Myers Squibb made up 0.11% of Frec Markets's portfolio in Q3 2026, its #181 holding.
  • Frec Markets first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.